ATOSSA THERAPEUTICS, INC. Accrued Liabilities, Current
ATOSSA THERAPEUTICS, INC. (ATOS) had Accrued Liabilities, Current of $1.38 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-07
- 2026-06-30: Accrued Liabilities, Current $1.38M.
- 2026-03-31: Accrued Liabilities, Current $2.81M.
- 2025-12-31: Accrued Liabilities, Current $1.31M.
- 2025-09-30: Accrued Liabilities, Current $1.99M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.38M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $2.81M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $1.31M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $1.99M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $2.20M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $1.79M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $919.00K 10-K · filed 2026-03-25 | |
| 2024-09-30 | $1.69M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $1.91M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $1.61M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $973.00K 10-K · filed 2025-03-25 | |
| 2023-09-30 | $1.26M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $803.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $613.00K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $1.06M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $117.00K 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $834.00K 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $120.00K 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $204.00K 10-K · filed 2023-03-22 | |
| 2021-09-30 | $75.69K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $531.60K 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $151.16K 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $93.00K 10-K · filed 2022-02-28 | $93.37K 10-K · filed 2021-03-31 |
| 2020-09-30 | $85.17K 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $92.86K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $52.47K 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $77.89K 10-K · filed 2021-03-31 | |
| 2019-09-30 | $225.47K 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $53.48K 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $74.84K 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $177.07K 10-K · filed 2020-03-26 | |
| 2018-09-30 | $51.67K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $286.71K 10-Q/A · filed 2018-11-13 | |
| 2018-03-31 | $172.61K 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $90.11K 10-K · filed 2019-03-28 | |
| 2017-09-30 | $50.54K 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $44.02K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $34.61K 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $16.96K 10-K · filed 2018-03-08 | |
| 2016-09-30 | $12.48K 10-Q/A · filed 2017-03-21 | |
| 2016-06-30 | $75.77K 10-Q/A · filed 2017-03-21 | |
| 2016-03-31 | $169.00K 10-Q/A · filed 2017-03-21 | |
| 2015-12-31 | $463.68K 10-K/A · filed 2017-03-21 | |
| 2015-09-30 | $934.67K 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $1.90M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $1.12M 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $254.13K 10-K · filed 2016-03-30 | $444.86K 10-K · filed 2015-03-30 |
| 2014-09-30 | $393.70K 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $226.64K 10-Q · filed 2014-08-12 | |
| 2013-12-31 | $295.31K 10-K · filed 2015-03-30 | $399.48K 10-Q · filed 2014-08-12 |
| 2013-06-30 | $1.56M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $1.90M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $1.58M 10-Q · filed 2013-08-14 | $1.58M 10-K · filed 2013-03-28 |
| 2012-09-30 | $1.89M 10-Q/A · filed 2013-01-22 | |
| 2011-12-31 | $442.33K 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |